Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Zhonghua Wai Ke Za Zhi ; 47(9): 697-700, 2009 May 01.
Article in Chinese | MEDLINE | ID: mdl-19615242

ABSTRACT

OBJECTIVE: To evaluate the effects of urinary kallidinogenase on subarachnoid hemorrhage (SAH) in rabbits. METHODS: Rabbits symptomatic cerebral vasospasm model was built though Endo method, among the 40 rabbits, 8 died or had severe nervous system syndrome, the other 32 were randomly divided into 4 groups:group A, control group, injection of normal saline to the cisterna magna;group B, subarachnoid hemorrhage;group C, injection of human urinary tissue kallikreins;group D, treated with Nimodipine. The behavior scores, neurological scores and cerebral angiography changes were observed. RESULTS: Food intake obviously decreased and neurological deficit were seen in group B, while which were attenuated in group C and group D, and group A was normal. Comparing the diameter of basilar artery was (1.9 +/- 0.3) mm before SAH, the diameter of group B 4 d later was (1.5 +/- 0.3) mm, 7 d later (1.4 +/- 0.3) mm, the difference was significant (P < 0.05). Comparing with group C on the day 4th and 7th, the diameters of basilar artery were significantly different (P < 0.001). Comparing with group D on the day 4th, 7th and 14th, there was no obvious improvement. CONCLUSION: Urinary kallidinogenase and Nimodipine can obviously alleviate symptomatic cerebral vasospasm in rabbits remarkably, but the former's effect of attenuating vasospasm is better than that of Nimodipine.


Subject(s)
Tissue Kallikreins/therapeutic use , Vasodilator Agents/therapeutic use , Vasospasm, Intracranial/drug therapy , Animals , Disease Models, Animal , Female , Humans , Male , Nimodipine/therapeutic use , Rabbits , Random Allocation
2.
Zhonghua Yi Xue Za Zhi ; 88(29): 2069-72, 2008 Jul 29.
Article in Chinese | MEDLINE | ID: mdl-19080438

ABSTRACT

OBJECTIVE: To study the effects of human tissue kallikrein (HTK) on symptomatic cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH). METHODS: Forty rabbits underwent occlusion of bilateral carotid. Two weeks later the 28 surviving rabbits were randomly divided into to 4 groups: shamed-operation group (n = 8) undergoing injection of normal saline into the cisterna magna on day 1 and day 3, SAH group (n = 6) undergoing injection of nonheparinized autologous arterial blood into the cisterna magna, HTK therapy group (n = 6) undergoing blood injection into the cisterna magna and then injection of HTK via ear marginal vein daily for 3 days, and nimodipine (ND) therapy group (n = 6) undergoing blood injection into the cisterna magna and then injection of ND via ear marginal vein. 3-dimension-CT angiography (3-D CTA) was used to measure the basilar artery diameter on D(0) and D(5). On D(6) the rabbits were killed with their basilar arteries taken out to undergo light microscopic examination. RESULTS: Blood could be seen in the basis cephalic of the 3 groups undergoing blood injection. 3-D CTA showed that arteriospasm was seen in the SAH and ND groups but not in the HTK group. Microscopy showed obvious pathological changes in basilar artery in the SAH and ND groups but not in the HTK group. CONCLUSION: HTK given early after SAH effectively alleviates the symptomatic cerebral vasospasm.


Subject(s)
Tissue Kallikreins/therapeutic use , Vasospasm, Intracranial/therapy , Animals , Blood Transfusion/methods , Female , Humans , Injections, Intravenous , Male , Rabbits , Subarachnoid Hemorrhage/therapy , Tissue Kallikreins/administration & dosage , Treatment Outcome , Vasospasm, Intracranial/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...